Related Experiment Videos
[Richter's syndrome (bimorphologic malignant lymphoma)].
D Holománová1, A Varga, M Mistrík
1Klinika hematológie a transfuziológie FN, Bratislava.
Vnitrni Lekarstvi
|April 24, 2002
Summary
Richter's syndrome involves the transformation of chronic lymphocytic leukemia (CLL) into aggressive non-Hodgkin lymphoma (NHL). This transformation can occur as a late event or an initial presentation of CLL, with chemotherapy potentially influencing its development.
Area of Science:
- Hematology
- Oncology
- Pathology
Background:
- Malignant lymphomas can present as distinct morphological types within a single patient.
- Chronic lymphocytic leukemia (CLL) is a common low-grade lymphoma.
- Transformation into aggressive non-Hodgkin lymphoma (NHL) is a known complication.
Observation:
- Richter's syndrome is characterized by the transformation of CLL into a high-grade lymphoma.
- A clonal relationship exists between CLL and the subsequent NHL.
- Richter's syndrome is more prevalent in CLL patients with chromosomal aberrations or monoclonal gammopathies.
Findings:
- Two types of Richter's syndrome are recognized: 'classical' (terminal event in evolving CLL) and 'variant' (initial presentation of unrecognized CLL).
- Aggressive chemotherapy for CLL may contribute to the development of Richter's syndrome.
Implications:
- Understanding the distinct types of Richter's syndrome is crucial for accurate diagnosis and management.
- Identifying risk factors like chromosomal aberrations and monoclonal gammopathies can aid in early detection.
- The role of chemotherapy in transformation warrants further investigation for optimizing treatment strategies.